Skip to main content
OpenTrials

Clinical trial condition

Hyperlipidemia

Explore clinical trials studying Hyperlipidemia. Study availability and eligibility vary by location and protocol.

343 public trials 22 recruiting studies
Refine in advanced search Browse all conditions

Hyperlipidemia trial results

Completed

A Coronary IVUS Study to Compare Torcetrapib/Atorvastatin to Atorvastatin Alone in Subjects With Coronary Heart Disease

NCT00134173

Conditions
Arterial Occlusive Diseases, Arteriosclerosis, Cardiovascular Diseases, +12 more
Locations
  • Pfizer Investigational Site Birmingham, Alabama, United States
  • Pfizer Investigational Site Mobile, Alabama, United States
  • Pfizer Investigational Site Little Rock, Arkansas, United States
  • Pfizer Investigational Site Fresno, California, United States
View all 146 locations
View Trial Details
Completed

A Clinical Trial Comparing Torcetrapib/Atorvastatin To Simvastatin In Subjects With High Cholesterol.

NCT00267254

Conditions
Dyslipidemia, Dyslipidemias, Hypercholesterolemia, +5 more
Locations
  • Pfizer Investigational Site Birmingham, Alabama, United States
  • Pfizer Investigational Site Mobile, Alabama, United States
  • Pfizer Investigational Site Mesa, Arizona, United States
  • Pfizer Investigational Site Phoenix, Arizona, United States
View all 49 locations
View Trial Details
Completed

Lipitor Trial To Study The Effect Of Torcetrpib/Atorvastatin To Atorvastatin Alone.

NCT00137462

Conditions
Dyslipidemias, Hyperlipidemia, Hyperlipidemias, +3 more
Locations
  • Pfizer Investigational Site Huntsville, Alabama, United States
  • Pfizer Investigational Site Union Grove, Alabama, United States
  • Pfizer Investigational Site Fresno, California, United States
  • Pfizer Investigational Site Los Angeles, California, United States
View all 59 locations
View Trial Details
Completed

Study To Evaluate The Safety And Efficacy Of Torcetrapib/Atorvastatin In Subjects With Familial Hypercholerolemia

NCT00134485

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dyslipidemias, Genetic Diseases, Inborn, +10 more
Locations
  • Pfizer Investigational Site San Diego, California, United States
  • Pfizer Investigational Site Washington D.C., District of Columbia, United States
  • Pfizer Investigational Site Lutz, Florida, United States
  • Pfizer Investigational Site Tampa, Florida, United States
View all 41 locations
View Trial Details

Related conditions